# Assessment of Netosis During COVID-19, Under Treatment With Anakinra, an Interleukin-1 Receptor Antagonist

> **NCT04594356** · — · COMPLETED · sponsor: **Fondation Hôpital Saint-Joseph** · enrollment: 120 (actual)

## Conditions studied

- Covid19

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04594356
- **Lead sponsor:** Fondation Hôpital Saint-Joseph
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-19
- **Primary completion:** 2021-01-31
- **Final completion:** 2023-04-26
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2023-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04594356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04594356, "Assessment of Netosis During COVID-19, Under Treatment With Anakinra, an Interleukin-1 Receptor Antagonist". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04594356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*